Gilead submits another sNDA

GILD and partner Hoffmann-La Roche (SWX:ROCZ) submitted to the FDA an sNDA for GILD's Tamiflu oseltamivir to treat acute illness due to influenza in children one year and older. Tamiflu, an oral neura...